People starting hyperbaric oxygen therapy (HBOT) often ask a sharp, practical question: will the treatment that's supposed to help me end up making my ears ring, my head hurt, or my body drag? The honest answer is nuanced. HBOT can trigger or aggravate all three of these symptoms in some patients, but the mechanisms, the frequency, and the seriousness differ enormously from one symptom to the next.
This guide walks through what the published evidence actually shows for tinnitus, headaches, and fatigue during and after HBOT. It separates the well-documented from the anecdotal, flags where the data are thin or industry-tilted, and tells you which symptoms are usually harmless and which are signals to slow down.
How HBOT Works and Why Side Effects Happen
HBOT puts you inside a sealed chamber and raises the surrounding pressure above normal sea-level air pressure. You then breathe oxygen at a much higher concentration than the 21% in room air. The combination of pressure and oxygen dissolves far more oxygen into your blood plasma, which is the point of the therapy.
Two features of that process drive almost every side effect. First, the pressure change itself. Air-filled spaces in your body, mostly your middle ears and sinuses, have to equalize as the chamber pressurizes and depressurizes. If they can't keep up, you get barotrauma. Second, the oxygen load. Breathing oxygen at high pressure floods tissues with reactive oxygen species (ROS), unstable molecules that are useful in small doses but harmful in large ones.
So when you hear about HBOT side effects, almost all of them trace back to one of these two roots: pressure stress on air-filled cavities, or oxidative stress from too much oxygen. Tinnitus is mostly a pressure problem. Headaches can come from either. Fatigue is mostly an oxidative and metabolic story. Understanding which root a symptom comes from tells you how worried to be and what to do about it.
There's a third factor that shapes how badly any of these hit: dose. In HBOT, dose isn't one number. It's a combination of pressure (measured in atmospheres absolute, or ATA), session length, how many sessions you do, and how often. A "mild" protocol at 1.3 ATA for 60 minutes is a very different stress than a "medical" protocol at 2.4 ATA for 90 minutes, repeated 40 times. The higher and longer the dose, the more both pressure stress and oxidative stress accumulate. This is why the same therapy can feel almost effortless for one person on a gentle protocol and rough for another on an aggressive one. Keep dose in mind as you read; it's the single biggest lever on side-effect risk.
Tinnitus and HBOT: The Two-Way Relationship
Tinnitus, the perception of ringing, buzzing, or hissing in the ears with no external source, has an unusual relationship with HBOT. The therapy is sometimes used to treat tinnitus, and it can also cause tinnitus as a side effect. Both things are true, which is why this topic confuses patients.
When HBOT Causes Tinnitus
The most common physical side effect of HBOT, by a wide margin, is middle ear barotrauma (MEB). It happens when the pressure inside the middle ear can't equalize with the rising chamber pressure during compression. The eardrum gets pushed inward, the lining swells, and in worse cases fluid or blood collects behind the drum. Tinnitus is one of the recognized symptoms of MEB, alongside ear fullness, pain, muffled hearing, and, rarely, eardrum rupture.
How often does MEB happen? It depends heavily on how you count and what pressure you treat at. A large retrospective review of a military population (1,446 patients, 31,599 treatments) found an MEB incidence of roughly 2% per patient. By contrast, a multicenter retrospective study of monoplace chambers reported ear pain (otalgia) in about 33% of patients when any degree of discomfort was counted, with treatment pauses needed in a smaller fraction. The gap between 2% and 33% isn't a contradiction; it reflects whether you're counting clinically significant injury or any ear symptom at all. Tinnitus specifically is a less common feature than simple pain or fullness, and when it appears as part of barotrauma it usually fades as the ear heals.
The mechanism is worth understanding because it tells you how to prevent it. As the chamber pressurizes, the eustachian tube, the narrow channel connecting the middle ear to the back of the throat, must open repeatedly to let air in and equalize the pressure. If it doesn't open fast enough, a relative vacuum forms in the middle ear and pulls the eardrum inward. Research on the pathophysiology notes that the hyperoxic environment itself can impair eustachian tube function, and that monoplace chambers, where you're surrounded by 100% oxygen, may make equalization harder than multiplace chambers where you breathe oxygen through a mask in normal air. The compression phase, not the steady "bottom" of the treatment, is when barotrauma almost always happens. That's actionable: the first few minutes of every session are when your equalization technique matters most.
There's also a difference between the symptom you notice and the injury a clinician would grade. Doctors often use the modified TEED scale to rank barotrauma from grade 0 (symptoms only, no visible change) up through redness, fluid, and frank bleeding behind the eardrum. Mild tinnitus or fullness with a normal-looking eardrum is at the bottom of that scale and resolves on its own. Tinnitus that comes with significant pain, hearing loss, or a visibly abnormal eardrum sits higher and may mean pausing treatment until the ear heals.
When HBOT Is Used to Treat Tinnitus
Here the evidence is genuinely disappointing, and it's worth being blunt about it. HBOT has been studied for tinnitus that comes alongside idiopathic sudden sensorineural hearing loss (the kind of sudden hearing loss with no clear cause). The landmark Cochrane systematic review on this question found that for acute sudden hearing loss treated within two weeks of onset, HBOT improved hearing thresholds in a statistically meaningful way. But for tinnitus itself, the reviewers could not demonstrate a benefit, and they explicitly did not recommend HBOT for chronic hearing loss or for tinnitus.
In plain terms: if you already have long-standing tinnitus, the published trials do not support paying for HBOT to fix it. If you have brand-new sudden hearing loss with tinnitus, there's a reasonable case for trying HBOT early as an add-on, but the tinnitus component specifically has the weakest support. Be skeptical of any clinic that markets HBOT as a tinnitus cure, especially for ringing you've had for months or years.
Headaches and HBOT: Usually Benign, Occasionally a Warning
Headache during or after HBOT is common, usually mild, and almost always traceable to a non-dangerous cause. But headache is also one of the early warning signs of the most serious HBOT complication, central nervous system (CNS) oxygen toxicity. The trick is telling the two apart.
The Common, Harmless Headaches
Most HBOT-related headaches come from one of three sources. Sinus barotrauma, the sinus version of the ear problem, can produce a pressure headache across the forehead or cheeks, especially if you're congested. Carbon dioxide buildup and the simple act of breathing high-pressure oxygen can cause a dull headache in some people. And after sessions, a brief tension or "decompression" headache can show up as the body readjusts. In the monoplace multicenter study, headache was reported in only about 1.6% of patients as a complaint significant enough to record, which tells you that recorded, bothersome headaches are uncommon even if mild transient ones go underreported.
The Headache That Matters: Oxygen Toxicity
CNS oxygen toxicity is the rare but feared complication. Breathing oxygen at high pressure can over-excite the brain. The classic warning signs, sometimes remembered by the mnemonic VENTID, include Vision changes, Ear ringing, Nausea, Twitching (especially of the face and lips), Irritability, and Dizziness. Headache can accompany these. The endpoint of CNS toxicity is a generalized seizure.
Here's the reassuring part: seizures are extremely rare at standard clinical pressures. The most-cited safety study, Seizure incidence in 80,000 patient treatments with hyperbaric oxygen, documented only 2 seizures across 80,000 treatments, an incidence of about 2.4 per 100,000 treatments, and both occurred at the higher pressure of 2.4 ATA. Seizures from HBOT are self-limiting once the oxygen is removed and leave no lasting damage in the vast majority of cases. Still, a new headache combined with facial twitching, visual disturbance, or rising anxiety inside the chamber is not something to push through. Tell the operator immediately.
Why is pressure so central to this risk? CNS oxygen toxicity scales steeply with the partial pressure of oxygen your brain is exposed to. At 1.3 to 2.0 ATA, the brain's exposure stays well below the threshold where most people seize. Push to 2.4 ATA or higher and the margin narrows, which is exactly why the rare documented seizures cluster at those pressures and why protocols above 2.4 ATA are reserved for emergencies like serious carbon monoxide poisoning or decompression sickness. It's also why "mild" HBOT at 1.3 ATA carries essentially negligible toxicity-headache risk, even if its proven benefits are more limited. The dose that makes the therapy work harder is the same dose that makes the warning headache more likely.
A few things raise an individual's susceptibility beyond pressure alone: fever, certain medications, low blood sugar, high carbon dioxide levels from breath-holding or anxiety, and a personal history of seizures. None of these are absolute barriers, but they're reasons a good clinic screens you before a course and watches more closely during it.
Fatigue and HBOT: Real, Common, and Usually Temporary
Fatigue is probably the most talked-about HBOT side effect online and the least dangerous. Many patients report feeling drained for several hours, or even a full day, after a session, particularly in the first week or two of a treatment course. It is common enough that some clinics deliberately schedule treatments Monday through Friday and pause on weekends to let patients recover.
Why HBOT Can Make You Tired
The leading explanation is oxidative stress and the body's adaptive response to it. A session floods tissues with ROS. In moderate amounts this is the mechanism behind many of HBOT's claimed benefits, because the ROS surge activates protective genetic pathways, most notably the Nrf2/HO-1 antioxidant system, which then ramps up the body's own defenses. This is a hormesis effect: a small, controlled stress that triggers a beneficial adaptation. The flip side is that mounting that adaptive response, plus the metabolic cost of stimulated tissue repair, can leave you feeling tired. Lying still in a confined space for 60 to 120 minutes, sometimes after taking time off work to get there, adds a plain physical and mental drain on top.
It's worth being honest that much of the detailed mechanistic story (the Nrf2 pathway, the repair-energy demand) is reasoned from laboratory and animal studies rather than proven as the direct cause of human post-session tiredness. The fatigue is real and commonly reported; the precise biochemical "why" is a well-supported hypothesis, not settled fact.
When Fatigue Is and Isn't a Concern
For most people, post-HBOT fatigue is mild, fades within 24 hours, and often eases as the body acclimates over the first several sessions. Hydration, a normal meal, and rest handle it. Fatigue that is severe, worsens over the course of treatment rather than improving, or comes with shortness of breath, chest tightness, or a persistent dry cough deserves a conversation with the supervising physician, because progressive fatigue plus respiratory symptoms can point toward pulmonary oxygen toxicity, a separate and more serious issue seen mainly with intensive or prolonged dosing.
Side-by-Side: How These Three Symptoms Compare
The table below summarizes the three target symptoms against the best available evidence. Frequency figures are approximate and vary with chamber type, treatment pressure, and how each study defined the symptom.
| Symptom | Root cause | How common | Severity | Typical course | Evidence quality |
|---|---|---|---|---|---|
| Tinnitus (as side effect) | Middle ear barotrauma from pressure changes | Uncommon as an isolated symptom; ear pain/fullness far more common (~2% significant barotrauma, up to ~33% any ear discomfort) | Usually mild, occasionally signals significant barotrauma | Resolves as ear heals, days to weeks | Moderate; multiple retrospective cohorts |
| Headache | Sinus barotrauma, CO2/oxygen effect, or early CNS oxygen toxicity | Mild headaches common but underrecorded; recorded bothersome headache ~1.6% | Usually benign; rarely a toxicity warning sign | Brief, resolves after session | Moderate for benign causes; strong safety data on seizures |
| Fatigue | Oxidative stress, adaptive antioxidant response, metabolic repair cost, confinement | Very commonly reported, especially early in a course | Mild and self-limiting in most | Hours to ~1 day; often improves as body adapts | Weak-to-moderate; mechanism inferred, frequency from clinical reports |
The Broader Side-Effect Picture
Tinnitus, headache, and fatigue don't exist in isolation. To judge their seriousness, it helps to see them against the full HBOT side-effect profile. A 2023 systematic review and meta-analysis of 24 randomized controlled trials (1,497 participants) found that adverse events occurred more often with HBOT than control (about 30% vs 10%), but that the overwhelming majority were mild and self-limiting. Two factors drove higher rates: treatment pressure at or above 2.0 ATA, and longer courses of more than 10 sessions. The table below ranks the main side effects.
| Side effect | Approximate frequency | Reversible? | Notes |
|---|---|---|---|
| Middle ear barotrauma (pain, fullness, sometimes tinnitus) | Most common physical side effect; ~2% significant, higher for minor discomfort | Yes | Worse at higher pressure; equalization technique helps |
| Reversible myopia (temporary nearsightedness) | Common with long courses; cited near ~75% over many sessions | Yes, over weeks to months | From oxygen effect on the lens; vision drifts back |
| Sinus barotrauma / sinus headache | Common, especially if congested | Yes | Worse with colds or allergies |
| Fatigue | Commonly reported | Yes | Usually improves with acclimation |
| Claustrophobia / anxiety | A few percent; chamber-type dependent | Yes | Worse in tight monoplace chambers |
| Cataract progression | Rare; mainly after 100+ sessions | No (lens change) | Not a concern for standard courses |
| CNS oxygen toxicity (seizure) | ~2.4 per 100,000 treatments | Yes, self-limiting | Mainly at 2.4 ATA; no lasting harm in most cases |
| Pulmonary oxygen toxicity | Rare with standard dosing | Yes if caught early | Linked to intensive/prolonged exposure |
The pattern is clear. The truly serious complications (seizures, pulmonary toxicity, permanent lens changes) are rare and tied to high pressure or unusually long, intensive treatment. The everyday symptoms patients actually feel (ear issues, headache, fatigue, temporary vision blur) are common but mild and reversible.
Who Should Be Extra Cautious
HBOT is contraindicated outright in untreated pneumothorax (collapsed lung) and requires caution with certain conditions and drugs. For the three symptoms in this guide, a few groups warrant extra care. People with chronic sinus disease, allergies, or frequent ear infections are more prone to barotrauma and the tinnitus or headache that comes with it. People with a history of seizures need physician review before starting, since seizure threshold matters for CNS toxicity risk. And anyone on medications that affect oxygen metabolism or the lungs should have those reviewed before a course begins.
If you're weighing HBOT for any reason, it pays to understand the full safety landscape, not just these three symptoms. See our deeper dives on HBOT side effects, ear pain, fatigue, and eye changes, on oxygen toxicity in HBOT and its real risks, and on when HBOT is genuinely dangerous. For the tinnitus question specifically, our HBOT for tinnitus evidence atlas breaks down every trial, and our broader side effects and risks overview puts it all in context.
Practical Steps to Reduce These Symptoms
Most of these symptoms can be prevented or softened. To protect your ears and cut barotrauma-related tinnitus and headache, learn active equalization techniques (swallowing, yawning, the gentle Valsalva maneuver) and use them early and often during compression, before pressure builds. Don't dive if you have an active cold or bad congestion; reschedule. Ask the clinic to slow the compression rate if your ears struggle.
For oxygen-toxicity-type headaches, the standard safeguard is air breaks, short periods of breathing room air during longer or higher-pressure sessions, which reset the oxygen load and reduce toxicity risk. Speak up the moment you notice visual changes, facial twitching, or unusual anxiety.
For fatigue, hydrate before and after, eat a normal meal, and plan a lighter rest of the day after early sessions. If fatigue is worsening across a course rather than easing, raise it with the supervising physician rather than just pushing through.
Frequently Asked Questions
Can HBOT permanently damage my hearing or cause lasting tinnitus?
Permanent damage is rare. Tinnitus from HBOT almost always comes from middle ear barotrauma, which typically heals as the ear recovers over days to weeks. Lasting injury is uncommon and usually involves a severe, unaddressed barotrauma or eardrum rupture. Equalizing properly and skipping sessions when congested sharply lowers the risk.
Is feeling tired after HBOT a sign that something is wrong?
Usually not. Mild fatigue for a few hours, especially in the first week or two of treatment, is one of the most commonly reported and least concerning effects, and it often eases as your body adapts. The exception is fatigue that gets worse across the course or comes with a dry cough, chest tightness, or breathlessness, which should be reported to the supervising physician.
Should I stop HBOT if I get a headache during a session?
It depends on the headache. A mild sinus-pressure or dull headache that eases after the session is usually benign. But a headache paired with facial or lip twitching, vision changes, ringing in the ears, nausea, or rising anxiety can be an early warning of central nervous system oxygen toxicity. Tell the chamber operator right away rather than pushing through.
Does HBOT actually treat tinnitus, or just cause it?
Both can happen, but the treatment evidence is weak. For long-standing or chronic tinnitus, the Cochrane review found no demonstrated benefit and did not recommend HBOT. There's a better case for trying HBOT early (within about two weeks) for sudden hearing loss with tinnitus, though even there the tinnitus component has the least support. Be wary of clinics marketing HBOT as a tinnitus cure.
Are these side effects worse at higher pressure?
Generally yes. The meta-analysis found higher adverse-event rates at pressures of 2.0 ATA and above, and longer courses (more than 10 sessions) also raised risk. Barotrauma, headache, and the rare seizure are all more likely at higher pressure. This is one reason lower-pressure protocols are often used when the clinical situation allows.
This article is for educational purposes only and is not medical advice. Hyperbaric oxygen therapy carries real risks and should be undertaken only under qualified medical supervision. Talk to a physician before starting or stopping any treatment.
Sources: Cochrane review: HBOT for sudden hearing loss and tinnitus · Seizure incidence in 80,000 HBOT treatments · Adverse effects of HBOT: systematic review and meta-analysis (Frontiers in Medicine, 2023) · Side effects in monoplace chambers: retrospective multicenter study (PMC) · Update on middle ear barotrauma after HBOT (PMC) · Cleveland Clinic: Hyperbaric oxygen therapy benefits and side effects · StatPearls: Hyperbaric-related myopia and cataract formation · PubMed search: HBOT middle ear barotrauma